Quantcast
Channel: Positive Agenda | infojustice
Viewing all articles
Browse latest Browse all 183

Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp & Dohme: Others must follow

$
0
0
[Medicines Law & Policy] The Medicines Patent Pool, a UN-backed organisation whose mission is to expand access to essential medicines around the world, today announced its first agreement on a Covid-19 therapy. The deal comes in the form of a licence and technology transfer agreement with Merck Sharp & Dohme (MSD) on molnupiravir, an investigational therapy for Covid-19 patients. The Medicines Patent Pool expanded its mandate to include Covid-19 technologies in March 2020.

Viewing all articles
Browse latest Browse all 183

Trending Articles